Page 99 - Read Online

Page 16 of 18 Kouroumalis et al. Hepatoma Res 2018;4:34 I http://dx.doi.org/10.20517/2394-5079.2018.33

78. Pintér E, Helyes Z, Szolcsányi J. Inhibitory effect of somatostatin on inflammation and nociception. Pharmacol Ther 2006;112:440-56.
79. Chao TC, Chao HH, Chen MF, Lin JD. Somatostatin modulates the function of Kupffer cells. Reg Pept 1997;69:143-9.
80. Valatas V, Kolios G, Manoussou P, Xidakis C, Notas G, Ljumovic D, Kouroumalis EA. Secretion of inflammatory mediators by isolated
rat Kupffer cells: the effect of octreotide. Reg Pept 2004;120:215-22.
81. Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang W, Xiong YQ, Wu WZ, Wang L, Tang ZY, Sun HC. High expression of macrophage
colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma.
J Clin Oncol 2008;26:2707-16.
82. Wan S, Kuo N, Kryczek I, Zou W, Welling TH. Myeloid cells in hepatocellular carcinoma. Hepatology 2015;62:1304-12.
83. Wan S, Zhao E, Kryczek I, Vatan L, Sadovskaya A, Ludema G, Simeone DM, Zou W, Welling TH. Tumor associated macrophages
produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. Gastroenterology
2014;147:1393-404.
84. Sica A, Invernizzi P, Mantovani A. Macrophage plasticity and polarizationin liver homeostasis and pathology. Hepatology
2014;59:2034-42.
85. Xidakis C, Kolios G, Valatas V, Notas G, Mouzas I, Kouroumalis E. Effect of octreotide on apoptosis-related proteins in rat Kupffer
cells: a possible anti-tumour mechanism. Anticancer Res 2004;24:833-41.
86. Eggert T, Wolter K, Ji J, Ma C, Yevsa T, Klotz S, Medina-Echeverz J, Longerich T, Forgues M, Reisinger F, Heikenwalder M, Wang
XW, Zender L, Greten TF. Distinct functions of senescence-associated immune responses in liver tumor surveillance and tumor
progression. Cancer Cell 2016;30:533-47.
87. Li X, Yao W, Yuan Y, Chen P, Li B, Li J, Chu R, Song H, Xie D, Jiang X, Wang H. Targeting of tumour-infiltrating macrophages via
CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut 2017;66:157-67.
88. Baeck C, Wei X, Bartneck M, Fech V, Heymann F, Gassler N, Hittatiya K, Eulberg D, Luedde T, Trautwein C, Tacke F. Pharmacological
inhibition of the chemokine CCL2 (MCP-1) accelerates liver fibrosis regression by suppressing Ly-6C+ macrophage infiltration.
Hepatology 2014;59:1060-72.
89. Valatas V, Kolios G, Manousou P, Notas G, Xidakis C, Diamantis I, Kouroumalis E. Octreotide regulates CC but not CXC LPS-induced
chemokine secretion in rat Kupffer cells. Br J Pharmacol 2004;141:477-87.
90. Fujita T, Soontrapa K, Ito Y, Iwaisako K, Moniaga CS, Asagiri M, Majima M, Narumiya S. Hepatic stellate cells relay inflammation
signaling from sinusoids to parenchyma in mouse models of immune-mediated hepatitis. Hepatology 2016;63:1325-39.
91. Fujita T, Narumiya S. Roles of hepatic stellate cells in liver inflammation: a new perspective. Inflamm Regen 2016;36:1.
92. Lang A, Sakhnini E, Fidder HH, Maor Y, Bar-Meir S, Chowers Y. Somatostatin inhibits pro-inflammatory cytokine secretion from rat
hepatic stellate cells. Liver Int 2005;25:808-16.
93. Xidakis C, Lumovic D, Manoussou P, Notas G, Valatas V, Kolios G, Kouroumalis E. Production of pro- and anti-fibrotic agents by rat
Kupffer cells: the effect of octreotide. Dig Dis Sci 2005;50:935-41.
94. Pyronnet S, Bousquet C, Najib S, Azar R, Laklai H, Susini C. Antitumor effects of somatostatin. Mol Cell Endocrinol 2008;286:230-7.
95. Shaaban S, Negm A, Ibrahim EE, Elrazak AA. Chemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and
mode of action. Oncol Rev 2014;8:246.
96. Schindel DT, Grosfeld JL. Hepatic resection enhances growth of residual intrahepatic and subcutaneous hepatoma, which is inhibited by
octreotide. J Pediatr Surg 1997;32:995-7.
97. Papalampros E, Felekouras ES, Filis K, Angelopoulou R, Kourelis T, Tsamandas AC, Bastounis E. Liver pathology and cell proliferation
after octreotide administration following partial hepatectomy in rats: an experimental study. Dig Dis Sci 2002;47:1953-8.
98. Hua YP, Huang JF, Liang LJ, Li SQ, Lai JM, Liang HZ. The study of inhibition effect of octreotide on the growth of hepatocellular
carcinoma xenografts in situ in nude mice. Zhonghua Wai Ke Za Zhi 2005;43:721-5. (in Chinese)
99. Jia WD, Xu GL, Wang W, Wang ZH, Li JS, Ma JL, Ren WH, Ge YS, Yu JH, Liu WB. A somatostatin analogue, octreotide, inhibits
the occurrence of second primary tumors and lung metastasis after resection of hepatocellular carcinoma in mice. Tohoku J Exp Med
2009;218:155-60.
100. Xie Y, Chen S, Wang C, Tang C. SOM230 combined with celecoxib prolongs survival in nude mice with HepG-2 xenografts. Cancer
Biol Ther 2011;12:86-92.
101. Tong H, Li X, Zhang CL, Gao JH, Wen SL, Huang ZY, Wen FQ, Fu P, Tang CW. Transcatheter arterial embolization followed by
octreotide and celecoxib synergistically prolongs survival of rabbits with hepatic VX2 allografts. J Dig Dis 2013;14:29-37.
102. Tong H, Li X, Zhang CL, Gao JH, Wen SL, Huang ZY, Tang CW. Octreotide and celecoxib synergistically encapsulate VX2 hepatic
allografts following transcatheter arterial embolisation. Exp Ther Med 2013;5:777-82.
103. Borbath I, Leclercq IA, Abarca-Quinones J, Desaeger C, Lebrun V, Moulin P, Sempoux C, Horsmans Y. Inhibition of early preneoplastic
events in the rat liver by the somatostatin analog lanreotide. Cancer Sci 2007;98:1831-9.
104. Borbath I, Leclercq IA, Sempoux C, Abarca-Quinones J, Desaege C, Horsmans Y. Efficacy of lanreotide in preventing the occurrence of
chemically induced hepatocellular carcinoma in rats. Chem Biol Interact 2010;183:238-48.
105. Borbath I, Stärkel P. Chemoprevention of hepatocellular carcinoma. Proof of concept in animal models. Acta Gastroenterol Belg
2011;74:34-44.
106. Abdel-Hamid NM, Mohafez OM, Nazmy MH, Farhan A, Thabet K. The effect of co-administration of Lawsonia inermis extract and
octreotide on experimental hepatocellular carcinoma. Environ Health Prev Med 2015;20:195-203.
107. Wang XX, Ye T, Li M, Li X, Qiang O, Tang CW, Liu R. Effects of octreotide on hepatic glycogenesis in rats with high fat dietinduced
obesity. Mol Med Rep 2017;16:109-18.